secwatch.observer — SEC 8-K summary
======================================

Issuer:     Virtuix Holdings Inc. (VTIX)
CIK:        0001606242
Form:       8-K
Filed at:   2026-05-29T21:00:16+00:00
Accession:  0001213900-26-062908
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Virtuix wins Air Force SBIR Phase I, expands into neurodivergent therapy, restructures debt with Streeterville
--------------------------------------------------------------------------------

- U.S. Air Force AFWERX SBIR Phase I award to develop Virtual Terrain Walk for immersive mission planning using Omni One treadmills.
- Rutgers University deploys Omni One platform for AI-assisted neurodivergent therapy research, including autism therapy.
- Exchanged $3.32M of convertible notes with Streeterville Capital for new $3.47M Pre-Paid Purchase at 6% interest.
- Pre-Paid Purchase allows Streeterville to purchase common shares at fixed price; no additional cash to company.
- Phase II SBIR funding typically exceeds $1M; VTW enables warfighters to physically walk geo-specific virtual terrain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606242/000121390026062908/0001213900-26-062908-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606242/000121390026062908/ea0291960-8k_virtuix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-062908

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer